Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease - Wikidata - awgldk - TriplyDB

Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease

Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease

http://www.wikidata.org/entity/Q36576387

about

Senescence-accelerated OXYS rats: a model of age-related cognitive decline with relevance to abnormalities in Alzheimer disease.Antagonistic analogs of growth hormone-releasing hormone increase the efficacy of treatment of triple negative breast cancer in nude mice with doxorubicin; A preclinical study Amyloid accumulation is a late event in sporadic Alzheimer's disease-like pathology in nontransgenic rats.Effects of growth hormone-releasing hormone on sleep and brain interstitial fluid amyloid-β in an APP transgenic mouse model New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor.Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function.Linkage analyses in Caribbean Hispanic families identify novel loci associated with familial late-onset Alzheimer's disease.Epigenetic mechanisms underlying cognitive impairment and Alzheimer disease hallmarks in 5XFAD mice Powerful inhibition of experimental human pancreatic cancers by receptor targeted cytotoxic LH-RH analog AEZS-108.Peripheral activities of growth hormone-releasing hormone.Suppression of the proliferation of human U-87 MG glioblastoma cells by new antagonists of growth hormone-releasing hormone in vivo and in vitro.

P2860

Q30760387-BAFED7DB-BD67-407E-B67E-B3EFC172BCEB Q34781112-536D56DD-09A9-4A20-B000-1CD78B231346 Q35176315-439B6EA0-C040-4314-8CFD-8FE46AAF21A2 Q35185668-788909C6-D7AD-4003-B029-799E10E85341 Q35833122-46409AFE-AD60-48B5-8EB3-3D74A7B0AA3B Q36189529-098D70B5-075A-4134-B08A-2A2BD1E3D9F0 Q36403205-F9E1ABF1-ABE1-454B-A22A-D69FBA02108A Q37049088-FCEF8F01-26E1-4FE4-AB94-25ACEC5C3D4E Q37093547-3578848A-EB8D-4016-A471-FE371E47B594 Q38739640-7F89335C-953A-45D2-8B5D-6EF8F8747674 Q39201247-1696D860-7AD9-4D3A-B796-854FFBDFFD43

P2860

Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease

http://www.wikidata.org/entity/Q36576387

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Beneficial effects of novel an ...... models of Alzheimer's disease

@ast

Beneficial effects of novel an ...... models of Alzheimer's disease

@en

type

label

Beneficial effects of novel an ...... models of Alzheimer's disease

@ast

Beneficial effects of novel an ...... models of Alzheimer's disease

@en

prefLabel

Beneficial effects of novel an ...... models of Alzheimer's disease

@ast

Beneficial effects of novel an ...... models of Alzheimer's disease

@en

P1433

Q36576387-2CC6E360-1C27-4CF3-B518-E1290BE83C3F

P1476

Q36576387-D6F07023-81C0-4D22-886B-80DE049C9941

P2093

Q36576387-16DF45E5-D490-4EEE-BAAB-E5531EAF017F

Q36576387-41F0C0D6-3270-4C16-B58C-CFC0B8E53989

Q36576387-422B1DB3-0603-4E8C-A2B1-2F832EEADC26

Q36576387-53A4DB51-E92E-451B-9B03-287E05E21922

Q36576387-63A220D9-3074-44D2-8F48-4EFEB88DE76A

Q36576387-E829BD74-EE2F-43F7-BABF-F37180C1C996

P2860

Q36576387-01C76E9E-C450-474C-9CB4-BE418D0E4451

Q36576387-0505F2CF-AEA6-4079-86A2-098D977B582A

Q36576387-0843D09D-629B-4CEC-87DC-2EB189593973

Q36576387-0E228EAD-D9A7-4FD1-B800-17428577EC67

Q36576387-11E47EA7-8040-4CA3-8563-645AA4466FE1

Q36576387-12031391-EE20-4183-812A-2900804E3AE3

Q36576387-13641CE5-2EB5-4454-8AA8-E10977289EC8

Q36576387-1BFB84BA-4CB9-4241-8826-41FD6A5E1BD9

Q36576387-1C886B53-19DE-4F2A-A8F9-4ED4E350423A

Q36576387-2088C6C0-04CD-441C-B589-398A4D395EC0

P304

Q36576387-D9FB3144-35B5-4FB4-8787-716A7F407362

P31

Q36576387-51F44052-46F9-46CB-8B52-C332036383E6

P356

Q36576387-FE68A090-ECD1-4EFD-B9C5-CE4F13646E19

P433

Q36576387-5192511A-B72B-4E5C-BA3B-E995A2128A63

P478

Q36576387-A5E4C4B0-ADBD-4EEA-92E7-413686DEC3B3

P50

Q36576387-E771898D-D15F-4092-BF5E-A820B64CECE0

P577

Q36576387-1F2E1E25-5C12-464A-B906-ABA3789AAC3D

P698

Q36576387-CBB51B69-EB98-4255-B12B-E6171A6DF7F8

P932

Q36576387-A70D7C2D-63C6-40BF-B975-DDF36E618A30

P356

P1433

P1476

Beneficial effects of novel an ...... models of Alzheimer's disease

@en

P2093

Ferenc G Rick

http://www.w3.org/2001/XMLSchema#string

Luca Szalontay

http://www.w3.org/2001/XMLSchema#string

Marta Zarandi

http://www.w3.org/2001/XMLSchema#string

Miklos Jaszberenyi

http://www.w3.org/2001/XMLSchema#string

Norman L Block

http://www.w3.org/2001/XMLSchema#string

Ren-Zhi Cai

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer's Disease

TMP21 is a presenilin complex component that modulates gamma-secretase but not epsilon-secretase activity

Effects of a growth hormone-releasing hormone antagonist on telomerase activity, oxidative stress, longevity, and aging in mice

The amyloid precursor protein: beyond amyloid

Morris water maze: procedures for assessing spatial and related forms of learning and memory

A critical role for IGF-II in memory consolidation and enhancement.

Developments of a water-maze procedure for studying spatial learning in the rat

Cytoskeletal pathologies of Alzheimer disease

Reduced IGF-1 signaling delays age-associated proteotoxicity in mice

Growth and aging: a common molecular mechanism.

P304

755-767

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/AGING.100504

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23211425

http://www.w3.org/2001/XMLSchema#string

P932

3560443

http://www.w3.org/2001/XMLSchema#string